Skip to main content
Bladder Cancer, Immunotherapy, FDA Updates
FDA Grants Priority Review to Keytruda for Patients with High-Risk, Non–Muscle-Invasive Bladder Cancer
Read More
FDA Updates
Inrebic Receives FDA Approval for Adults with Myelofibrosis
Read More
FDA Updates
FDA Approved Erleada for Metastatic Castration-Sensitive Prostate Cancer
Read More
FDA Updates
Keytruda plus Lenvima Combo FDA Approved for Advanced Endometrial Carcinoma with No MSI-H or dMMR Tumors
Read More
Lung Cancer
Long-Term Data Confirm Survival Benefit for Pembrolizumab in Advanced NSCLC
Phoebe Starr
Read More
Ovarian Cancer
The Burden of Ovarian Cancer Affects Multiple Dimensions of Women’s Lives
Read More
Ovarian Cancer
The Epidemiology of Ovarian Cancer: Different Prognoses for Different Populations
Read More
Ovarian Cancer
Multiple Risk Factors Are Associated with the Development of Ovarian Cancer
Read More
Ovarian Cancer
Ovarian Cancer Screening Is Not Recommended for Asymptomatic Women of Average Risk
Read More
FDA Updates
FDA Approves Adakveo to Reduce Vaso-Occlusive Crises in Patients with Sickle-Cell Disease
Read More
Page 144 of 196
Results 1431 - 1440 of 1954